Cita APA

Herold, K. C., Gitelman, S. E., Masharani, U., Hagopian, W., Bisikirska, B., Donaldson, D., . . . Bluestone, J. A. (2005). A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes. Diabetes.

Citación estilo Chicago

Herold, Kevan C., et al. "A Single Course of Anti-CD3 Monoclonal Antibody HOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for At Least 2 Years After Onset of Type 1 Diabetes." Diabetes 2005.

Cita MLA

Herold, Kevan C., et al. "A Single Course of Anti-CD3 Monoclonal Antibody HOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for At Least 2 Years After Onset of Type 1 Diabetes." Diabetes 2005.